AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040
22/12/2025 – AB Science today announced that the United States Patent Office has formally granted a patent for methods of treating sickle cell disease using its lead compound masitinib, based on preclinical data